A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs.
Krystal’s mission is to develop and deliver genetic medicines to patients using redosable gene therapies for the treatment of severe, life‑threatening or rare diseases that have limited or no approved therapies.